Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
6.00
3.93
65.50%
Share Warrants & Outstandings
Total Reserve
-24.79
23.61
-48.40
-205.00%
Shareholder's Funds
-14.87
29.61
-44.48
-150.22%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.00
18.53
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.00
18.53
0.00%
Deferred Tax Assets / Liabilities
-0.90
-1.40
0.50
35.71%
Other Long Term Liabilities
0.00
0.10
-0.10
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.98
-0.98
-100.00%
Total Non-Current Liabilities
17.62
-0.33
17.95
5,439.39%
Current Liabilities
Trade Payables
2.57
18.90
-16.33
-86.40%
Other Current Liabilities
1.79
2.09
-0.30
-14.35%
Short Term Borrowings
3.05
1.28
1.77
138.28%
Short Term Provisions
2.74
5.69
-2.95
-51.85%
Total Current Liabilities
10.15
27.96
-17.81
-63.70%
Total Liabilities
12.91
57.24
-44.33
-77.45%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
1.68
26.08
1,552.38%
Less: Accumulated Depreciation
22.49
1.10
21.39
1,944.55%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.58
4.69
808.62%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
3.95
-3.94
-99.75%
Long Term Loans & Advances
1.29
2.46
-1.17
-47.56%
Other Non Current Assets
0.00
3.34
-3.34
-100.00%
Total Non-Current Assets
6.57
10.44
-3.87
-37.07%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
2.42
1.71
70.66%
Sundry Debtors
1.41
20.57
-19.16
-93.15%
Cash and Bank
0.04
6.17
-6.13
-99.35%
Other Current Assets
0.74
12.41
-11.67
-94.04%
Short Term Loans and Advances
0.02
5.23
-5.21
-99.62%
Total Current Assets
6.34
46.80
-40.46
-86.45%
Net Current Assets (Including Current Investments)
-3.81
18.84
-22.65
-120.22%
Total Current Assets Excluding Current Investments
6.34
46.80
-40.46
-86.45%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
57.24
-44.33
-77.45%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.58
1.28
20.30
1,585.94%
Book Value per share (adjusted)
-14.98
49.34
-64.32
-130.36%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
